Expression of extracellular matrix proteins fibulin-1 and fibulin-2 by human corneal fibroblasts

Current Eye Research

Volumn 32, Issue 6, 2007, Pages 481-490

  Ducros, E ^a   Berthaut, A ^a,b   Mirshahi, P ^a   Lemarchand, S ^a   Soria, J ^a   Legeais, J M ^b   Mirshahi, M ^a  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

Cell motility; Corneal fibroblasts; Extracellular matrix; Fibulin 1; Fibulin 2

Indexed keywords

AGGRECAN; ENDOSTATIN; ENTACTIN; FIBRILLIN 1; FIBULIN 1; FIBULIN 2; LAMININ ALPHA2; MATRIGEL; MATRIX METALLOPROTEINASE; MESSENGER RNA; POLYSTYRENE; PROTEIN ADAMTS 1; SCLEROPROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL IMMORTALIZATION; CELL MIGRATION; CELL MOTILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; VALIDATION PROCESS;

ADAM PROTEINS; AGGRECANS; CALCIUM-BINDING PROTEINS; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CORNEAL STROMA; ENDOSTATINS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; LAMININ; MEMBRANE GLYCOPROTEINS; MICROFILAMENT PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 34447117588     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701411269     Document Type: Article

References (34)

1. Midura RJ, Hascall VC, MacCallum DK, et al. Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular corneal dystrophy. J Biol Chem. 1990;265(26):15947-15955.
2. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352(6333):279-281.
3. Maslen CL, Corson GM, Maddox BK, et al. Partial sequence of a candidate gene for the Marfan syndrome. Nature. 1991;352(6333):279-281.
4. Hyams SW, Kar H, Neumann E. Blue sclerae and keratoglobus. Ocular signs of a systemic connective tissue disorder. Br J Ophthalmol 1969;53(1):53-58.
5. Francomano CA, Liberfarb RM, Hirose T, et al. The Stickler syndrome: evidence for close linkage to the structural gene for type II collagen. Genomics. 1987;1(4):293-296.
6. Fryer AE, Upadhyaya M, Littler M, et al. Exclusion of COL2A1 as a candidate gene in a family with Wagner-Stickler syndrome. J Med Genet. 1990;27(2):91-93.
7. Biglan AW, Brown SI, Cignetti FE, Linn JG. Corneal perforation in Wegener's granulomatosis treated with corneal transplantation: case report. Ann Ophthalmol. 1977;9(6):799-801.
8. Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some common diseases in humans. FASEB J 1991;5(7):2052-2060.
9. Argraves WS, Tran H, Burgess WH, Dickerson K. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J Cell Biol. 1990;111(6):3155-3164.
10. Timpl R, Sasaki T, Kostka G, Chu ML. Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol. 2003;4(6):479-489.
11. Strom A, Olin AI, Aspberg A, Hultgardh-Nilsson A. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration. Cardiovasc Res. 2006;69(3):755-763.
12. Hayashido Y, Lucas A, Rougeot C, Godyna S, Argraves WS, Rochefort H. Estradiol and fibulin-1 inhibit motility of human ovarian- and breast-cancer cells induced by fibronectin. Int J Cancer 1998;75(4):654-658.
13. Twal WO, Czirok A, Hegedus B, et al. Fibulin-1 suppression of fibronectin-regulated cell adhesion and motility. J Cell Sci. 2001;114(24):4587-4598.
14. Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep. 2003;4(12):1127-1131.
15. Kostka G, Giltay R, Bloch W, et al. Perinatal lethality and endothelial cell abnormalities in several vessel compartments of fibulin-1-deficient mice. Mol Cell Biol. 2001;21(20):7025-7034.
16. Gallagher WM, Currid CA, Whelan LC. Fibulins and cancer: friend or foe? Trends Mol Med. 2005;11(7):336-340.
17. Weigell-Weber M, Sarra GM, Kotzot D, Sandkuijl L, Messmer E, Hergersberg M. Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-1) in a previously undescribed vitreoretinal dystrophy. Arch Ophthalmol. 2003;121(8):1184-1188.
18. Stone EM, Lotery AJ, Munier FL, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22(2):199-202.
19. Hassell JR, Schrecengost PK, Rada JA, SundarRaj N, Sossi G, Thoft RA. Biosynthesis of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33(3):547-557.
20. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun TT, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest. 1995;72(4):461-473.
21. Aspberg A, Adam S, Kostka G, Timpl R, Heinegard D. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem. 1999;274(29):20444-20449.
22. Ohsawa I, Takamura C, Kohsaka S. Fibulin-1 binds the aminoterminal head of beta-amyloid precursor protein and modulates its physiological function. J Neurochem. 2001;76(5):1411-1420.
23. Lee NV, Rodriguez-Manzaneque JC, Thai SN, et al. Fibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1. J Biol Chem. 2005;280(41):34796-34804.
24. Katsanis N, Venable S, Smith JR, Lupski JR. Isolation of a paralog of the Doyne honeycomb retinal dystrophy gene from the multiple retinopathy critical region on 11q13. Hum Genet. 2000;106(1):66-72.
25. Chu ML, Tsuda T. Fibulins in development and heritable disease. Birth Defects Res C Embryo Today 2004;72(1):25-36.
26. Argraves WS, Dickerson K, Burgess WH, Ruoslahti E. Fibulin. A novel protein that interacts with the fibronectin receptor beta subunit cytoplasmic domain. Cell. 1989;58(4):623-629.
27. Trinkaus-Randall V, Capecchi J, Sammon L, Gibbons D, Leibowitz HM, Franzblau C. In vitro evaluation of fibroplasia in a porous polymer. Invest Ophthalmol Vis Sci. 1990;31(7):1321-1326.
28. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol. 1986;103(6 Pt 1):2499-2509.
29. Rada JA, Thoft RA, Hassell JR. Increased aggrecan (cartilage proteoglycan) production in the sclera of myopic chicks. Dev Biol. 1991;147(2):303-312.
30. Koga T, Inatani M, Hirata A, et al. Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea. Curr Eye Res. 2005;30(6):455-463.
31. Garner A. Amyloidosis of the cornea. Br J Ophthalmol. 1969;53(2):73-81.
32. Pouliquen Y, Dhermy P, Pouliquen M, Savoldelli M. Gelatinous drop-like dystrophy of the cornea (primary amylosis). J Fr Ophtalmol. 1981;4(5):349-357.
33. Wride MA, Geatrell J, Guggenheim JA. Proteases in eye development and disease. Birth Defects Res C Embryo Today. 2006;78(1):90-105.
34. Seeger RC, Danon YL, Rayner SA, Hoover F. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma, and teratoma cells with a monoclonal antibody. J Immunol. 1982;128(2):983-989.